Quarterly Report I 21/22
September 2021 – November 2021, Diamyd Medical AB (publ), Fiscal year 2021/2022Developing Precision Medicine Therapies for Type 1 DiabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period (parent company) previous financial year. September 1, 2021 – November 30, 2021 · Net result: MSEK -37.8 (104.9). The previous year contains a one-off effect of corresponding MSEK 117.5 from divestment of shares in Companion Medical,